ADMA Biologics (ADMA) Announces $200M Capital Return Program Including $125M ASR Agreement.
Share this article
Corporate
Score 65
Bullish
ADMA Biologics (ADMA) Announces $200M Capital Return Program Including $125M ASR Agreement
Mar 23, 2026 18:18 UTC
ADMA, XLV, IWB
Short term
Related Articles
Score 55
Bullish
Thailand’s Largest Mall Operator Plans $3.4 Billion Expansion
Mar 25, 07:07
Score 25
Scion of $6 Billion Carlyle Fortune Defies Private Equity Slump
Mar 25, 05:15
Score 65
Bullish
HSBC: See 'Explosion' of Demand for Life Solutions
Mar 25, 05:13
Score 75
Bullish
SK Hynix Files Confidentially for U.S. Listing Amid Memory Market Surge
Mar 25, 03:01
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.